HK1172830A1 - Ultrasound contrast agent dosage formulation - Google Patents

Ultrasound contrast agent dosage formulation

Info

Publication number
HK1172830A1
HK1172830A1 HK13100015.6A HK13100015A HK1172830A1 HK 1172830 A1 HK1172830 A1 HK 1172830A1 HK 13100015 A HK13100015 A HK 13100015A HK 1172830 A1 HK1172830 A1 HK 1172830A1
Authority
HK
Hong Kong
Prior art keywords
contrast agent
dosage formulation
ultrasound contrast
agent dosage
ultrasound
Prior art date
Application number
HK13100015.6A
Other languages
Chinese (zh)
Inventor
Richard Walovitch
Howard Bernstein
Donald E Chickering Iii
Julie Straub
Original Assignee
Acusphere Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acusphere Inc filed Critical Acusphere Inc
Publication of HK1172830A1 publication Critical patent/HK1172830A1/en

Links

HK13100015.6A 2004-06-04 2013-01-02 Ultrasound contrast agent dosage formulation HK1172830A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210028040.8A CN102600485B (en) 2004-06-04 2004-06-04 Ultrasonic contrast medium dosage formula

Publications (1)

Publication Number Publication Date
HK1172830A1 true HK1172830A1 (en) 2013-05-03

Family

ID=46518500

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13100015.6A HK1172830A1 (en) 2004-06-04 2013-01-02 Ultrasound contrast agent dosage formulation

Country Status (2)

Country Link
CN (1) CN102600485B (en)
HK (1) HK1172830A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201791437A1 (en) 2014-12-31 2017-12-29 Лантеус Медикал Имэджинг, Инк. COMPOSITIONS OF MICROSPHERE WITH GAS DISTRIBUTED IN LIPID AND RELATED METHODS
US9789210B1 (en) 2016-07-06 2017-10-17 Lantheus Medical Imaging, Inc. Methods for making ultrasound contrast agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ276167A (en) * 1993-12-15 1996-11-26 Bracco Research Sa Ultrasound contrast medium comprising two gases in aqueous suspension
US5837221A (en) * 1996-07-29 1998-11-17 Acusphere, Inc. Polymer-lipid microencapsulated gases for use as imaging agents

Also Published As

Publication number Publication date
CN102600485A (en) 2012-07-25
CN102600485B (en) 2014-10-22

Similar Documents

Publication Publication Date Title
IL213897A0 (en) Ultrasound contrast agent dosage formulation
IL186944A (en) Solid dosage colonic purgative formulation and various aspects related thereto
IL185390A (en) Solid pharmaceutical dosage formulation
HK1198914A1 (en) Novel dosage formulation
IL177566A0 (en) Pharmaceutical formulations
ZA200701557B (en) Pharmaceutical compositions comprising diclofenac
EP2093237A4 (en) Cancer therapeutic agent comprising anti-hb-egf antibody as active ingredient
GB0521139D0 (en) Therapeutic agent
GB0426301D0 (en) Pharmaceutical formulations
GB0615545D0 (en) Therapeutic agent
IL178067A0 (en) Pharmaceutical dosage forms and compositions
EP1819323A4 (en) Pharmaceutical composition containing an anti-nucleating agent
GB0316206D0 (en) Pharmaceutical formulation
GB0412530D0 (en) Formulation
HK1105358A1 (en) Solid pharmaceutical formulation
GB0416397D0 (en) Pharmaceutical formulations
EP1757282A4 (en) The use of kauranes compounds in the manufacture of medicament
HK1172830A1 (en) Ultrasound contrast agent dosage formulation
IL189827A0 (en) Pharmaceutical dosage forms and compositions comprising lecoztan
PL1688129T3 (en) New therapeutic formulation
EP1908467A4 (en) Herpesvirus-derived therapeutic agent for pain
GB0508153D0 (en) Therapeutic agent
EP1900363A4 (en) Therapeutic agent for pain
GB0406951D0 (en) Improved formulation
GB0418270D0 (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190601